tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Feedback plc Navigates Challenges with Strategic NHS Alignments and Key Contracts

Story Highlights
Feedback plc Navigates Challenges with Strategic NHS Alignments and Key Contracts

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Feedback ( (GB:FDBK) ) just unveiled an announcement.

Feedback plc reported its full-year results for the period ending 31 May 2025, highlighting several operational achievements despite financial challenges. The company secured significant contracts and funding, including a £495k digital infrastructure contract with Queen Victoria Hospital NHS Foundation Trust and further funding for a community diagnostic centre pilot. Feedback’s Bleepa platform played a crucial role in reducing patient wait times, earning an HSJ Partnership Award. However, revenue fell to £0.89m, down from £1.18m in 2024, and the company reported an EBITDA loss of £3.06m. Despite these setbacks, Feedback remains optimistic about future growth, supported by a successful £6.1 million fundraising and a strategic alignment with the NHS’s digital-first and collaborative vision.

Spark’s Take on GB:FDBK Stock

According to Spark, TipRanks’ AI Analyst, GB:FDBK is a Neutral.

Feedback plc’s overall score reflects a mixture of strengths and challenges. Strong balance sheet and strategic corporate alignments are positive, but persistent losses and cash flow issues raise concerns. Technical analysis indicates a bearish trend, while valuation metrics highlight difficulties due to negative earnings.

To see Spark’s full report on GB:FDBK stock, click here.

More about Feedback

Feedback plc is a clinical infrastructure specialist that focuses on liberating data and knowledge from multiple healthcare IT systems to improve clinician communication and collaboration. Their primary products include Bleepa, a communication and collaboration platform, and CareLocker, a patient-facing platform. The company operates in both public and private healthcare markets, with a significant focus on the NHS, and employs a scalable software-as-a-service model.

Average Trading Volume: 30,522

Technical Sentiment Signal: Sell

Current Market Cap: £5.81M

See more data about FDBK stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1